Skip to content

Clinical trials

Completed Pulmonary Eosinophilia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Status: Completed Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20142
20151
20161
20172
20182
20202
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
AstraZeneca3
AnaptysBio, Inc.1
Chiesi Farmaceutici S.p.A.1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
NHS Greater Glasgow and Clyde1
Queen Mary University of London1
University Hospital Southampton NHS Foundation Trust1
University of Nottingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia14
Asthma9
Anxiety Disorders1
Churg-Strauss Syndrome1
Eosinophilic Esophagitis1
Lung Diseases1
Mental Disorders1
Respiratory Tract Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.